End-of-life care in heart failure

Current Cardiology Reports

Volumn 11, Issue 3, 2009, Pages 184-191

  Goodlin, Sarah J ^a  

^a Patient centered Education and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPSAICIN; CAPTOPRIL; CARVEDILOL; CODEINE; DIAMORPHINE; DIHYDROCODEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; FENTANYL; GLYCERYL TRINITRATE; HYDROCODONE; HYDROMORPHONE; INOTROPIC AGENT; LOOP DIURETIC AGENT; METHADONE; METHYLPHENIDATE; MORPHINE SULFATE; NESIRITIDE; PSYCHOSTIMULANT AGENT; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ANEMIA; ANOREXIA; ANTICHOLINERGIC SYNDROME; BEREAVEMENT; CACHEXIA; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COMMUNICATION SKILL; CONTINUOUS INFUSION; DEFIBRILLATOR; DEPRESSION; DOCTOR PATIENT RELATION; DYSPNEA; FAMILY DECISION MAKING; FATIGUE; FLUID RETENTION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPICE CARE; HUMAN; HYPONATREMIA; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; PAIN; PATIENT EDUCATION; PROGNOSIS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SODIUM RESTRICTION; SUDDEN DEATH; TERMINAL CARE; TREATMENT PLANNING; VERTEBRAL CANAL STENOSIS;

ADVANCE DIRECTIVES; AGED; AGED, 80 AND OVER; ATTITUDE TO DEATH; COMMUNICATION; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HOSPICE CARE; HUMANS; LIFE SUPPORT CARE; MALE; PATIENT RIGHTS; PHYSICIAN-PATIENT RELATIONS; QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIGHT TO DIE; SENSITIVITY AND SPECIFICITY; SPIRITUAL THERAPIES; TERMINAL CARE; UNITED STATES;

EID: 65549086521     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-009-0027-7     Document Type: Review

References (50)

1. Ko DT, Alter DA, Austin PC, et al.: Life expectancy after an index hospitalization for patients with heart failure: A population-based study. Am Heart J 2008, 155:324-331.
2. Mozaffarian D, Anker SD, Anand I, et al.: Prediction of mode of death in heart failure: The Seattle Heart Failure Model. Circulation 2007, 116:392-398.
3. Remme WJ, Cleland JG, Erhardt L, et al.: Effect of carvedilol and metoprolol on the mode of death in patients with heart failure. Eur J Heart Fail 2007, 9:1128-1135.
4. Teuteberg JJ, Lewis EF, Nohria A, et al.: Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail 2006, 12:47-53.
5. Derfler MC, Jacob M, Wolf RE, et al.: Mode of death from congestive heart failure: Implications for clinical management. Am J Geriatr Cardiol 2004, 13:299-304.
6. Carson P, Anand I, O'Connor C, et al.: Mode of death in advanced heart failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005, 46:2329-2334.
7. Kim DH, Hunt SA: HeaCt failure management: caregiver versus care plan. Circulation 2003, 108:129-131.
8. Komajda M, Hanon O, Hochadel M, et al.: Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey 1. Eur Heart J 2007, 28:1310-1318.
9. Yamoski LM, Hasselblad V, Moser DK, et al.: Prediction of rehospitalization and death in severe heart failure by physicians and nurses in the ESCAPE trial. J Card Fail 2007, 13:8-13.
10. Lee DS, Austin PC, Rouleau JL, et al.: Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. JAMA 2003, 290:2581-2587.
11. Levy WC, Mozaffarian D, Linker DT, et al.: The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006, 113:1424-1433.
12. Huynh BC, Rovner A, Rich MW: Identification of older patients with heart failure who may be candidates for hospice care: Development of a simple four-item risk score. J Am Geriatr Soc 2008, 56:1111-1115.
13. Goodlin SJ, Kutner J, Connor S, et al.: Hospice care for heart failure patients. J Pain Symptom Manag 2005, 29:525-528.
14. Hauptman PJ, Swindle J, Hussain Z, et al.: Physician attitudes toward end-stage heart failure: A national survey. Am J Med 2008, 121:127-135.
15. Goodlin SJ, Trupp R, Bernhardt P, et al.: Development and evaluation of the "Advanced Heart Failure Clinical Competence Survey": A tool to assess knowledge of heart failure care and self-assessed competence. Pat Educ Couns 2007, 67:3-10.
16. Allen LA, Yager JE, Fund MJ, et al.: Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA 2008, 299:2533-2542.
17. Goodlin SJ, Hauptman PJ, Arnold R, et al.: Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail 2004, 10:200-209.
18. Hauptman PJ, Havranek EP: Integrating palliative care into heart failure care. Arch Intern Med 2005, 165:374-378.
19. Goodlin SJ, Quill TE, Arnold RM: Communication and decision-making in heart failure. J Card Fail 2008, 14:106-113.
20. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group [no authors listed]. J Am Coll Cardiol 1983:755-763.
21. Packer M, Fowler MB, Roecker EB, et al.: Effect of carvedilol on the morbidity of patients with severe chronic heart failure. Circulation 2002, 106:2194-2199.
22. Krum H, Sackner-Bernstein JD, Goldsmith RL, et al.: Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995, 92:1499-1506.
23. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709-717.
24. Evangelista LS, Moser DK, Westlake C, et al.: Correlates of fatigue in patients with heart failure. Prog Cardiovasc Nurs 2008, 23:12-17.
25. Mancini DM, Katz SD, Lang CC, et al.: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003, 107:294-299.
26. Colin Ramirez E, Castillo Martinez L, Orea Tejeda A, et al.: Effects of a nutritional intervention on body composition, clinical status and quality of life in patients with heart failure. Nutrition 2004, 20:890-895.
27. Bradley TD, Logan AG, Kimoff RJ, et al.: Continuous positive airway pressure for central sleep apnea and heart failure. CANPAP investigators. N Engl J Med 2005, 353:2025-2033.
28. Arzt M, Bradley TD: Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006, 173:1300-1308.
29. Weber KT: Furosemide in the long-term management of heart failure. The good, the bad and the uncertain. J Am Coll Cardiol 2004, 44:1308-1310.
30. Conraads VM, Beckers P, Vaes J, et al.: Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004, 25:1797-1805.
31. Beniaminovitz A, Lang CC, LaManca J, Mancini DM: Selective low-level leg muscle training alleviates dyspnea in patients with heart failure. J Am Coll Cardiol 2002, 40:1602-1608.
32. Belardinelli R, Georgiou D, Cianci G, et al.: Randomized controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life and clinical outcome. Circulation 1999, 99:1173-1182.
33. Johnson MJ: Morphine for the relief of breathlessness in patients with chronic heart failure Eur Heart J 2002, 4:753-756.
34. Chua TP, Harrington D, Ponikowski P, et al.: Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997, 29:147-152.
35. Williams SG, Wright DJ, Marshall P, et al.: Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 2003, 89:1085-1086.
36. Weir MR: Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 2002, 69:SI53-SI58.
37. Page J, Henry D: Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An under-recognized public health problem. Arch Intern Med 2000, 160:777-784.
38. Mamdani M, Juurlink DN, Lee DS, et al.: Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study. Lancet 2004, 363:1751-1756.
39. Hryniewicz K, Androne AS, Hudaihed A, Katz SD: Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Fail 2003, 9:464-468.
40. Anker SD, Negassa A, Coats AJ, et al.: Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: An observational study. Lancet 2003, 361:1077-1083.
41. Archana R, Gray D: The quality of life in chronic disease - heart failure is as bad as it gets. Eur Heart J 2002, 23:1806-1808.
42. Murray SA, Kendall M, Boyd K, et al.: Exploring the spiritual needs of people dying of lung cancer or heart failure: A prospective qualitative interview study of patients and their carers. Palliat Med 2004, 18:39-45.
43. Horne G, Payne S: RPmoving the boundaries: palliative care for patients with heart failure Palliat Med 2004, 18:291-296.
44. Gillian R, Pulchalski CM: Spiritual support in heart failure patients. In Supportive Care in Heart Failure. Edited by Beattie J, Goodlin SJ. New York, NY: Oxford University Press; 2008:299-318.
45. Puchalski C, Romer AL: Taking a spiritual history allows clinicians to understand patients more fully. J Palliat Med 2000, 3:129-137.
46. Sullivan M, Levy WC, Russo JE, Spertus JA: Depression and health status in patients with advanced heart failure: A prospective study in tertiary care. J Card Fail 2004, 10:390-396.
47. Bekelman DB, Sullivan M: Depression and anxiety in patients with chronic heart failure. In Supportive Care in Heart Failure. Edited by Beattie J, Goodlin SJ. New York, NY: Oxford University Press; 2008:273-298.
48. Stuart B, Alexander C, Arenella C, et al.; for Standards and Accreditation Committee, Medical Guidelines Task Force: Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. Arlington, VA: National Hospice Organization; 1996.
49. Hauptman PJ, Goodlin SJ, Lopatin M: Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med 2007, 167:1990-1997.
50. Hershberger RE, Nauman D, Walker TL, et al.: Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003, 9:180-187.